Sodium-glucose cotransporter 2 inhibitors and neurological disorders: a scoping review

• Principais autores: Thahesh Tharmaraja (Autor), Jamie S.Y. Ho (Autor), Ching-Hui Sia (Autor), Nicole-Ann Lim (Autor), Yao Feng Chong (Autor), Amanda Y.L. Lim (Autor), Rahul R. Rathakrishnan (Autor), Leonard L.L. Yeo (Autor), Vijay K. Sharma (Autor), Benjamin Y.Q. Tan (Autor)
• Formato: Livro
• Publicado em: SAGE Publishing, 2022-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a group of antidiabetic medications with a favourable cardiovascular, renal and overall safety profile. Given the limited treatment options available for neurological disorders, it is important to determine whether the pleiotropic ef...